BPMC
Walleye Capital’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.16M | Sell |
16,830
-25,365
| -60% | -$3.25M | 0.01% | 603 |
|
|
2025
Q1 | $3.73M | Buy |
42,195
+14,305
| +51% | +$1.27M | 0.02% | 430 |
|
|
2024
Q4 | $2.43M | Buy |
27,890
+24,641
| +758% | +$2.15M | 0.01% | 635 |
|
|
2024
Q3 | $301K | Sell |
3,249
-6,495
| -67% | -$601K | ﹤0.01% | 1540 |
|
|
2024
Q2 | $1.05M | Buy |
9,744
+8,156
| +514% | +$879K | ﹤0.01% | 1101 |
|
|
2024
Q1 | $151K | Buy |
+1,588
| New | +$151K | ﹤0.01% | 1901 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2334 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2152 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2180 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2171 |
|
|
2022
Q3 | – | Sell |
-5,234
| Closed | -$264K | – | 2307 |
|
|
2022
Q2 | $264K | Buy |
+5,234
| New | +$264K | 0.01% | 1356 |
|
|
2022
Q1 | – | Sell |
-15,461
| Closed | -$1.66M | – | 2227 |
|
|
2021
Q4 | $1.66M | Buy |
+15,461
| New | +$1.66M | 0.05% | 371 |
|
|
2020
Q3 | – | Sell |
-2,628
| Closed | -$205K | – | 829 |
|
|
2020
Q2 | $205K | Buy |
+2,628
| New | +$205K | 0.05% | 425 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 564 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 693 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 547 |
|